On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.

The following is a summary of “Cost-effectiveness and cost-utility of exposure-based vs. traditional cognitive behavior therapy for fibromyalgia: results from a randomized controlled trial,” published ...

On February 7, 2025, the U.S. National Institutes of Health announced a decision to cap indirect cost reimbursement-which supports the critical infrastructure and staff that make biomedical ...

It is imperative to align strategies that can prevent ovarian cancer while also strengthening support for patients, caregivers, and health systems that are confronted by it,” the researchers wrote.